The at-home genetic testing market is booming. Worth $99m in 2017, it is estimated by healthcare market research company Kalorama Information that this could top $300m by 2022.
Every year there are more companies offering some variation on the service where, in return for you spitting in a tube and popping it in the post, they will break down everything from your family’s ancestry to full genome sequencing or your predisposition to certain diseases.
Its rapid rise has been driven by two factors. Firstly, costs are falling – drastically. Where such a service would once have set you back millions of dollars, Read full story ›
Source: The Drum
Industry News